| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ad66884a6f2a66126d492e56e09be39 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714 |
| filingDate |
1988-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11627fae32ffc16ddccfead968a319a6 |
| publicationDate |
1988-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-8806036-A1 |
| titleOfInvention |
Pharmaceutical compositions for treating obstructive air passage diseases |
| abstract |
Obstructive air passage disease, in particular bronchial asthma is treated with a pharmaceutical product comprising in combination a xanthine, preferably theophyline in its non-ethylene diaminated form and vitamin B6. Specific embodiments include riboflavin and zinc ion. The ingredients are formulated in a slow release form. The vitamin B6 is in the form of pyridoxine (PN). An alternative embodiment for treating acute cases is adapted for infusion and contains 50 to 100 % of the vitamin B6 in the form of pyridoxal (PL). Ascorbic acid is included as an antioxidant. The zinc ion can be complexed with vitamin B6. Daily dosage rates for human adults are 5 to 500 mg PN and 50 to 600 mg theophylline. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0416248-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0416248-A2 |
| priorityDate |
1987-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |